Research programme: apoptosis inducers - BioLineRx
Alternative Names: BL-4030Latest Information Update: 16 Jul 2016
At a glance
- Originator University of Illinois at Urbana-Champaign
- Developer BioLineRx; University of Illinois at Urbana-Champaign
- Class Antineoplastics; Small molecules
- Mechanism of Action Apoptosis stimulants; Caspase 3 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in Israel
- 26 Jul 2007 Preclinical trials in Cancer in Israel (unspecified route)